Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

Anju Murayama, Sae Kamamoto, Kohki Yamada, Divya Bhandari, Iori Shoji, Hanano Mamada, Moe Kawashima, Erika Yamashita, Hiroaki Saito, Eiji Kusumi, Toyoaki Sawano, Binaya Sapkota, Tetsuya Tanimoto, Akihiko Ozaki
doi: https://doi.org/10.1101/2022.03.09.22271972

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted March 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
Anju Murayama, Sae Kamamoto, Kohki Yamada, Divya Bhandari, Iori Shoji, Hanano Mamada, Moe Kawashima, Erika Yamashita, Hiroaki Saito, Eiji Kusumi, Toyoaki Sawano, Binaya Sapkota, Tetsuya Tanimoto, Akihiko Ozaki
medRxiv 2022.03.09.22271972; doi: https://doi.org/10.1101/2022.03.09.22271972
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area